Press Releases ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 17/04/2026 BST			5-day change	1st Jan Change
119.68 ^USD	+3.55%		+12.05%	-34.32%

03-26	On Wall Street, The Cost of Waiting It Out
03-26	Analyst recommendations: Adobe, Fiserv, Chewy, Oklo, Qualcomm…

Press Releases

03-24	ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model	BU
03-16	Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm	AQ
02-18	ICON INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating ICON plc on Behalf of ICON Stockholders and Encourages Investors to Contact the Firm	AQ
02-18	ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement	PR
02-17	ICLR ALERT: Securities Fraud Investigation by Block & Leviton Could Allow ICON pcl Investors to Recover Losses	NE
02-13	ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues - Hagens Berman	PR
02-12	Ademi LLP Investigates Claims of Securities Fraud against ICON plc	PR
02-12	ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices	BU
01-27	ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership	BU
12-09	ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive	BU
12-02	ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions	BU
11-12	ICON plc to Present at the Jefferies London Healthcare Conference	BU
23/10/25	ICON Public : Q3 2025 Press Release V14 FINAL	PU
22/10/25	Icon PLC: Q3 Earnings Snapshot	AQ
22/10/25	ICON Reports Third Quarter 2025 Results	BU
24/09/25	ICON plc Schedules Third Quarter 2025 Earnings Conference Call	BU
04/09/25	ICON Announces CEO Transition	BU
02/09/25	ICON plc to Participate at Upcoming Investor Conferences	BU
24/07/25	ICON Public : Press Release - ICON Reports Second Quarter 2025 Results Final	PU
23/07/25	Icon PLC: Q2 Earnings Snapshot	AQ
23/07/25	ICON Announces Results of Annual General Meeting	BU
23/07/25	ICON Reports Second Quarter 2025 Results	BU
16/07/25	ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report	BU
07/07/25	ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability	BU
23/06/25	ICON plc Schedules Second Quarter 2025 Earnings Conference Call	BU